Rapamycin inhibits the proliferation and metabolic reprogramming of HUTU 80 cells
Small bowel adenocarcinoma (SBA) is a rare malignant tumor of the gastrointestinal tract. At present, there is no standard treatment approach for late-stage patients with SBA which is associated with poor outcomes and prognosis.